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Abstract: The aim of this study was to investigate the prevalence of naturally acquired immune response to malaria 
in individuals of different age groups belonging to areas of northern India, Loni PHC (LN) and Dhaulana PHC (SD) 
of district Ghaziabad. Plasmodium falciparum-infected erythrocyte lysate and six synthetic peptides from different 
stages of P. falciparum (CSP, MSP1, AMA1, RAP1, EBA175 and PfG27) were used to determine both humoral and 
cellular immune responses. Plasma of individual subject was also analyzed for IL-4, IL-10, IFN-γ and TNF-α level. 
We observed an age-wise increasing trend of immunity in these two populations. There was a significant association 
between the number of antibody responders and recognition of stage-specific epitopes by antibodies. Peripheral 
blood mononuclear cells of more than 75% of individuals proliferated in response to stimulation by all the antigens 
in LN area. IL-4 and IL-10 responses were significantly higher in individuals of LN Area; whereas IFN- and   
TNF- responses were higher in individuals of SD Area. It was also noticed that the frequency of responders to 
stage-specific antigens was higher in individuals from the LN area where the frequency of malaria was lower. The 
naturally acquired immune responses to P. falciparum antigens reflected the reduced risk of malaria in the study 
groups. The results demonstrated immunogenicity of the epitopes to P. falciparum in population of this endemic 
zone. 
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1. Introduction 
 
In areas where malaria is endemic, the acquisition 
of antimalarial immune protection is progressive, as 
observed by age-wise decrease of morbidity and 
mortality to malarial infection [1, 2]. Acquired 
immunity to malaria is achieved in adults as a 
cumulative effect after repeated exposure [3]. The 
humoral response to various antigens of Plasmodia is 
considered to be one of the important mechanisms 
mediating this immune state [4]. Malaria caused by 
Plasmodium falciparum remains a serious disease in the 
world endangering the life and development of infants 
and young children [5]. It is established from earlier 
studies that some of the important antigens, which 
induce protective responses were shared by P. 
falciparum parasites of different geographic regions [6].  
Panels of stage specific antigens of P. falciparum 
have been characterized; they were taken to evaluate 
their immunogenicity for their inclusion in a malaria 
vaccine [5, 7, 8]. Several antigens of P. falciparum 
erythrocytic merozoite stage are under investigation for 
their inclusion in a subunit vaccine, among them 
merozoite surface proteins 1 and 2 (MSP1 and MSP2), 
the apical membrane antigen-1 (AMA1), rhoptry 
associated protein-1 (RAP1) and erythrocyte binding 
antigen-175 (EBA175) showed high immunogenicity 
producing partial or total protection in simian malaria 
[9]. Sera of the inhabitants living in malaria endemic 
areas showed marked immunoglobulin-G reactivities to 
these antigens [8, 10, 11, 12, 13, 14, 15]. The 
circumsporozoite protein (CSP) and thrombospondin 
related adhesive protein (TRAP), as well as liver stage 
antigens 1 and 3 (LSA-1 and LSA-3), are the most 
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promising of these components. It was demonstrated 
that irradiated sporozoites were excellent material for a 
malaria vaccine, and a vaccine was assembled using the 
circumsporozoite (CS) protein [16, 17]. Recently, a 
switch from the original alum adjuvant to a more recent 
adjuvant and immune enhancer, along with the addition 
of an immunogenic fusion partner, namely the S 
antigen of hepatitis B (HBsAg), has caused the CS 
protein to be re-evaluated as a component in a vaccine 
against malaria. In fact, as RTS,S the CS protein is now 
showing great promise in trials in Africa [18, 19]. Study 
of the mosquito stage, where the idea is to reduce the 
chances of contact between the vector and the human 
host, has produced many potential targets that aim at 
the parasite’s sexual stages. The most promising of 
these vaccine candidates are Pfs25 and Pfg27 [20, 21]. 
They have successfully shown the ability to block 
parasite infectivity to the mosquito vector, thus 
blocking the spread of the parasite between humans. 
In Plasmodial infections, the balances between pro- 
and anti-inflammatory cytokines determine the level of 
anaemia, parasite load, degree of pyrexia, clinical 
severity and outcome of infection [22, 23, 24]. The role 
of pro- and anti-inflammatory cytokines in immune 
response to P. falciparum infection is well documented 
[25, 26, 27]. Proinflammatory cytokines, such as 
tumour necrosis factor-alpha (TNF-α) and interferon-
gamma (IFN-γ) play a dominant role in the destruction 
of pathogens and confer protection, whereas cytokines 
like IL-4 and IL-10 are thought to play antagonistic 
roles and thus lowers the effect of TNF-α and IFN-γ 
[28, 29, 30]. 
Among Southeast Asian countries, India alone 
contributes more than 80% malaria cases and               
P. falciparum accounts for around 50% cases [31]. 
Large areas of India are under low to moderate intensity 
of malaria transmission. In these areas, immunity to 
malaria is generally low; adults attain immunity after 
repeated exposures. The present study was conducted in 
two subpopulations living more or less closely in two 
village areas of district Ghaziabad, Uttar Pradesh. 
Individuals of the two areas were studied for their 
parasitologic and immunologic profiles. In the present 
report, we determined the immunogenicity of              
P. falciparum-infected erythrocyte lysate (Pf-crude 
antigen) and six P. falciparum stage-specific peptides, 
CSP, MSP1, AMA1, RAP1, EBA175 and Pfg27 by 
evaluating both humoral and cellular responses in a 
population where malaria is seasonal and the 
inhabitants experience with the natural course of P. 
falciparum infection. 
 
2. Materials and Methods 
 
2.1 Study Areas & Subjects 
A cross-sectional survey was conducted from July 
to December 2007 in Ghaziabad district of Uttar 
Pradesh, in northern India, which is endemic for both  
P. vivax and P. falciparum malaria. The inhabitants of 
villages under Loni PHC (Area LN) and Dhaulana PHC 
(Area SD) participated in the study (Fig. 1). In these 
areas, malaria is seasonal; early and prolonged 
monsoons are responsible for intensive transmission of 
both the species. Among the anopheline population, 
Anopheles culicifacies is a most abundant vector 
followed by Anopheles annularis and Anopheles 
subpictus [32]. Blood samples were collected by active 
survey of fever cases for malaria. Axillary temperature 
was measured. Giemsa stained thick and thin blood 
smears were examined. Patients diagnosed with malaria 
were treated with recommended doses of antimalarials 
as per National Drug Policy. This study was approved 
by the Institutional Ethics Committee. Informed 
consent was obtained from all study subjects.  
 
 
 
Fig. 1. Study site. 
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2.2 Antigens  
 
2.2.1 P. falciparum crude antigen (PfC) 
PfC was prepared from a well adapted, established 
P. falciparum culture line by the published method 
[33]. Briefly, the parasite culture was maintained in 
vitro using human O+ RBC and AB+ serum by candle-
jar technique [34]. Cultures enriched with late 
trophozoites and schizont stages were taken in antigen 
preparation. Parasites were freed from host erythrocytes 
by saponin lysis and disrupted by sonication at 14μA 
for 90 seconds in a sonicator (MSE Soniprep, UK). The 
soluble extract was taken as antigen after centrifugation 
and purification by removing host contamination by 
adsorbing with rabbit antisera raised against human 
erythrocytes [35]. 
 
2.2.2 Peptides 
The immunodominant parts of P. falciparum 
CSP, MSP1, AMA1, RAP1, EBA175 and Pfg27 were 
used (Table 1). They were synthesized by Fmoc-
chemistry followed by purification through gel filtration 
chromatography [36, 37]. The purity of each peptide 
was assessed by HPLC and amino acid analysis. All the 
peptides were found to be >90% pure. They were used 
at a final concentration of 10μg/ml for ELISA and LTT. 
The details of the peptides used are given below:  
 
Circumsporozoite Protein (CSP): This is a major 
surface protein of sporozoites. It is nearly a 67kDa 
protein. All CSPs have a central region of tandemly 
repeated amino acids. 
Merozoite Surface Protein 1 (MSP1): It is 
synthesized by the intracellular schizont as a            
185-205kDa precursor protein. Following the 
proteolytic processing of the precursor, only carboxy-
terminal 19kDa remains on the surface. This fragment 
is a conserved region of MSP1. 
Apical Membrane Antigen 1 (AMA1): This 
protein is involved in the invasion of RBC. It is a 
66kDa protein located in the apical membrane of the 
merozoite. 
Rhoptry Associated Protein 1 (RAP1): This 
protein is also involved in the invasion of RBC. It is an 
80kDa protein located in rhoptry organelles of the 
merozoite. 
Erythrocyte Binding Antigen 175 (EBA175): 
The erythrocyte binding protein is located in the 
micronemes of P. falciparum. The Pf-EBA 175kDa is a 
sialic acid-binding protein. Antibodies to region II of 
EBA175 block erythrocyte binding and also inhibit 
merozoite invasion.  
Pf-Gametocyte Antigen 27 (Pfg27): This is a more 
potent immunogen of gametocytes of 25-27kDa. It is 
synthesized at the early stage of gametocytes when they 
are not even morphologically distinguishable. 
 
 
Table 1. Synthetic peptides from Plasmodium falciparum stage-
specific antigens. 
 
Antigens Sequences References 
CSP (NANP)3 [7] 
MSP1 NSGCFRHLDEREECKCLL [13] 
AMA1 DGNCEDIPHVNEFSAIDL [8] 
RAP1 LTPLEELY [10] 
EBA175 NEREDERTLTKEYEDIVLK [12] 
Pfg27 KPLDKFGNIYDYHYEH [20] 
 
2.3  Antibody estimation  
An indirect ELISA was performed following 
published protocol [1]. In brief, the 96-well round 
bottom polystyrene plates (Iwaki, Japan) were coated 
with individual peptides at a protein concentration of 
10μg/ml and with PfC antigen at 20μg/ml by incubating 
for 1 h at 37oC, then overnight at 4oC. Sera were tested 
at 1:200 dilutions in duplicate for each antigen. After 
addition of sera at a respective dilution onto the first 
layer, they were allowed to react for 1 h at 37oC and     
1 hr more at room temperature followed by addition of 
antihuman IgG conjugated with horseradish peroxidase 
(Dakopatts, Denmark) at an optimum dilution to trap 
the antigen-antibody complexes. After incubation for 1 
h at 37oC and 1 hr more at room temperature, the 
enzyme-specific substrate, ortho-
phenylenediamine/hydrogen peroxide (Sigma, Aldrich) 
was added. The reaction was terminated with 8N 
sulfuric acid and absorbance was read at 490nm in an 
ELISA reader (Microscan, ECIL, India) and results 
expressed as O.D. values. In each plate, reference 
antibody positive and negative samples were tested as 
controls. 
 
2.4  Lymphocyte proliferation assay 
This assay was done in a subset of 15 and 18 older 
children of Both LN and SD areas. Within 24 hr after 
bleeding, peripheral blood mononuclear cells (PBMC) 
were isolated from venous blood by density gradient. 
The proliferation assay was performed following 
published method with slight modification [13]. A total 
of 0.5x106 PBMCs was used in a volume of 200μl 
cultures per well in 96-well flat bottom tissue culture 
plates (Greiner, GmBH). All 6 peptides (CSP, MSP1, 
AMA1, RAP1, EBA175 and Pfg27) of P. falciparum 
were used at 1μg/ml; PfC and NRBC antigens at 
10μg/ml and phytohemagglutinin (SIGMA-Aldrich, 
USA) as positive control at 5μg/ml concentrations. 
After incubation for 120 h at 37oC in 5%, CO2 
atmosphere cultures were pulsed with 1μCi of 3H-
thymidine per well and incubated for 18 h. After 
incubation, the cultures were harvested and 
radioactivity measured in β-scintillation counter 
(Beckman, USA). 
 
2.5  Cytokines Assay 
Plasma of each subject was kept at -70oC until use. 
Cytokines as IFN-, IL-4, IL-10, TNF- were 
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determined by two-site sandwich ELISA using 
commercially developed two-site ELISA assay kits 
(Source: Peprotech Asia, Rocky hills, New Jersey, 
USA) following published method with slight 
modification [24]. Mean absorbance values were 
determined against known concentrations of IL-4,    
IFN-, IL-10 and TNF- by Sandwich ELISA to 
estimate cytokine concentrations in plasma.  
 
2.6  Data Analysis  
Parasite density in blood smears of study subjects 
was estimated by counting the number of parasites per 
200 leucocytes and the counts were converted to a 
number of parasites/μl blood taking 8000 leucocytes/μl 
as a standard mean [38]. For the purpose of analysis, 
the subjects of each area were divided into three age 
groups with corresponding parasitologic data. Each 
ELISA plate coated with individual antigen contained 
blank, reference negative and positive controls. 
Assaying 20 sera of non-malarial, non-endemic young 
adult’s determined cutoff values for negative sera. The 
thresholds for positivity for each antigen were set above 
mean OD+3 SD values of negative serum. ELISA OD 
values for each antigen were compared and differences 
between intra-group and inter-group were tested by 
one-way ANOVA. The ELISA OD values of sera from 
two areas tested against 7 antigens were compared to 
see correlation of seroresponsnes between antigens by 
Pearson’s coefficient of correlation. In vitro 
lymphocyte proliferation in the presence of various 
antigens was calculated by geometric mean counts per 
minute for each set of triplicate wells. The stimulation 
index (SI) was determined as the geometric mean 
counts per minute of antigen/mitogen stimulated culture 
divided by the geometric mean counts per minute of 
unstimulated culture. Cytokine estimation data were 
presented as mean ± SD/mean ± SEM/median (IQR). 
Box diagrams were plotted taking median values with 
25th and 75th percentiles, and bars for 10th and 90th 
percentiles of cytokine concentrations and values 
outside the 10th and 90th percentiles were plotted as 
points. For all tests, P values <0.05 were considered 
significant. 
 
3. Results and Discussion 
 
In surveying a population of 1223, malaria slides 
positive cases were 318 (26%), which include 214 P. 
falciparum and 104 P. vivax cases. Fig. 2 shows the 
epidemiological profile and parasite episodes of 
individuals belonging to LN and SD areas. Area LN 
and Area SD were distinguished on clinical and 
parasitologic data. In LN Area, children presented with 
one febrile episode associated with parasitaemia 
<5000/l; a less number of children found parasitaemic 
compared to SD Area. In SD Area, children presented 
with more than one parasite episodes associated with 
>5000/l. Based on this, from LN and SD areas, 81 and 
84 children of 1-<5 yr; 45 and 46 school children of    
5-15 yr age groups and a batch of 34 and 32 adults were 
selected for the immunologic study, respectively.  
In this study, we have monitored a population 
living in an endemic area of malaria, where the 
occurrence of seasonal fluctuations of transmission was 
envisaged. The P. falciparum parasitaemia among 
different age groups could not be correlated statistically 
as observed by other workers also [38]. In our study 
population, 32 and 78 children below 5 years; 26 and 
51 of 5-15 year; 11 and 16 above 15 years from LN and 
SD areas were found P. falciparum positive and mean 
parasitaemia was lower in LN area compared to SD 
(Table 2). The data on parasitaemia of two areas could 
suggest that they differ in malaria prevalence based on 
the number of P. falciparum positive cases. The P. 
falciparum parasitaemia among different age groups 
could not be correlated statistically. Both younger and 
older children were equally prone to P. falciparum 
infection. 
 
 
 
Fig. 2. Malaria profile in two areas (LN & SD) with seasonal transmission of malaria. 
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Table 2. Characteristics of study population. 
 
Study site Blood slide examined Age group Mean age (years) Malaria slide+ Pf+ (%) Pf count/µl 
LN 625 
1 to <5 yr 2.6 62 32 (25.4) 1550 
5 to 15 yr 10.6 45 26 (20.6) 8436 
>15 yr 32.3 19 11 (8.7) 7635 
SD 598 
1 to <5 yr 2.4 103 78 (40.6) 18900 
5 to 15 yr 10.2 72 51 (26.6) 15650 
>15 yr 31.5 17 16(8.3) 10645 
 
For immunologic investigation, synthetic peptides 
were used that represented epitopes from conserved and 
semiconserved regions of P. falciparum asexual/sexual 
blood stages. All 160 and 162 sera obtained from LN 
and SD areas were tested for their reactivity to             
P. falciparum antigens CSP, MSP1, AMA1, RAP1, 
EBA175, Pfg27 and parasite lysate (PfC). Figs. 3 and 4 
show the absorbance levels of antigen-specific IgG 
antibodies in various age groups indicating the intensity 
of immune responses and seroresponder frequency 
among younger and older children. Antibodies detected 
against the peptides and Pf crude antigen were lower in 
subjects from SD Area than LN (P <0.01). The adults 
of both LN and SD areas showed similar seroreactivity 
(P <0.05). In younger children, the antibody response 
rate to CSP, MSP1, EBA175, AMA1, RAP1, Pfg27 and 
Pf infected erythrocyte lysate was higher in children of 
both LN and SD areas  (P <0.01). In older children's 
groups, seropositivity to MSP1 and PFC was observed 
in almost all the subjects (P <0.05). In adult groups, 
almost all the individuals showed seropositivity to these 
antigens. 
The main objective of the study was to investigate 
whether naturally acquired immune responses to 
different stage-specific antigens of P. falciparum could 
reflect the less risk of infection in the study population. 
Evaluation of age-specific prevalence of antibodies to a 
variety of malarial antigens may help in exploration of 
trends in malaria endemicity in two subpopulations. 
Although the antigens of P. falciparum used here are to 
some extent polymorphic, they contain 
conserved/semiconserved sequences that induce strong 
antibody responses. In the present study, all six antigens 
clearly vary in immunogenicity; MSP1 appears to be 
highly immunogenic at moderate malaria endemicity. 
Our findings revealed an overall higher ELISA IgG 
reactivity for samples from LN compared to SD against 
the tested antigens. Age-associated pattern of ELISA 
reactivity may suggest that antibodies to all these stage-
specific antigens may represent serological markers of 
age-acquired immunity to distinguish between areas of 
different transmission intensity. We found that IgG 
responses to antigens were detectable in almost all 
donors. The highest prevalence of seropositivity 
occurred in subjects of more than 15 years age in both 
the areas as observed earlier also [4]. Among adults of 
both areas, seroprevalence was high, whereas parasite 
prevalence fell, which may be the expected outcome 
among individuals who acquired a significant degree of 
immunity [39]. Serological cohort studies are an 
efficient means of obtaining information on the force of 
infection in areas of very low transmission and single 
conversion events may be detected [40].  
 
 
 
 
Fig. 3. Antibody profile of study subjects in different age groups. Sera were tested for antimalarial IgG antibody against 6 Pf stage-specific 
peptides (CSP, MSP1, EBA175, AMA1, RAP1 and Pfg27) and Pf infected erythrocyte lysate (Pf crude). Antibodies detected against the 
peptides and Pf crude antigen were lower in subjects from SD Area than LN (P <0.01). The adults of both areas showed similar seroreactivity 
(P <0.05). 
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Fig. 4. Seroresponders frequency. In younger children, the antibody response rate to CSP, MSP1, EBA175, AMA1, RAP1, Pfg27 and Pf infected 
erythrocyte lysate was higher in children of both LN and SD Areas  (P <0.01). In older children's groups, seropositivity to MSP1 and Pf crude 
was observed in almost all the subjects (P <0.05). 
 
Lymphocyte proliferative response frequency in 
study cases of LN Area was higher (above 60%) 
compared to SD Area with antigens CSP, MSP1, 
AMA1, RAP1, EBA175 and Pf-C (P <0.001), but in 
Pfg27 peptide, the response was almost alike in 
children of both areas (Fig. 5). Cytokines as IFN-,    
IL-4, IL-10, TNF- were determined in plasma by two-
site sandwich ELISA (Fig. 6). IL-4 and IL-10 responses 
were significantly higher in individuals of LN Area     
(P <0.01), whereas IFN- and TNF- responses to these 
antigens were higher in individuals of SD Area            
(P <0.05). 
For P. falciparum malaria in humans, the existence 
of functionally different CD4+ T cells has been 
established experimentally in naturally exposed 
individuals. These T cells respond to malaria antigen in 
vitro by proliferation and by secretion of cytokines, 
such as IL-4 and IFN- [41]. The cytokines as IL-4 and 
IFN- have strong counterregulatory activity, failure to 
mount a strong IFN- responses may be a tendency to 
respond to malarial infection. Anti-inflammatory 
cytokines as IL-4 and IL-10 counteract the production 
of the pro-inflammatory cytokines. The cytokine,   
TNF- has a central role for both protection and 
malaria pathogenesis. The levels of TNF-α and IFN- γ 
(both pro-inflammatory) are also increased with the 
disease. In comparison to healthy normal’s (HC) both 
were elevated among the malaria cases (P <0.001). 
TNF-α and IFN-γ both are also known to check 
parasitaemia thus are important at early stage of the 
infection [23, 27]. But at very higher concentration 
these cytokines are harmful for the host itself. The most 
effective T-cell responses against malaria are those that 
promote production of specific antibodies. The use of 
all these epitopes in the context of vaccine could be 
determined based on the specific antibody and T-cell 
responses. But as such antigenicity of these epitopes 
could be brought under use in determining immune 
response in vitro. 
 
 
 
Fig. 5. Lymphocyte proliferation activity. Lymphocyte proliferative response frequency in study cases of LN Area was higher (above 60%) 
compared to SD Area with antigens CSP, MSP1, AMA1, RAP1, EBA175 and Pf-C (P <0.001), but in Pfg27 peptide, the response was almost 
alike in children of both areas (NS). 
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Fig. 6. Estimation of cytokines in plasma samples by two-site 
sandwich ELISA. Cytokines as IFN-, IL-4, IL-10, TNF- were 
determined by two-site sandwich ELISA. IL-4 and IL-10 responses 
were significantly higher in individuals of LN Area to all the 
antigens (P <0.01), whereas IFN- and TNF- responses to these 
antigens were higher in individuals of SD Area (P <0.05). 
 
4.  Conclusion 
 
All synthetic peptides were able to detect 
antibodies and also induce cellular responses in some 
individuals. In areas with moderate endemicity, 
antibody responses were observed in 30-90% of the 
donors of LN Area and 5-80% of SD Area to any given 
peptide. Age-wise increasing trend of antibody has been 
observed in individuals of both areas, which showed 
correlation with reduced malaria morbidity. Clinical 
protection was achieved in some individuals showed 
higher proliferative responses and elevated levels of 
antibodies to MSP1, AMA1, RAP1 and EBA175 
peptides. The overall immune responses among 
individuals of two ecotypes highlight the 
immunogenicity of these molecules and their relation to 
clinical protection. Results obtained from this study 
may be useful in monitoring natural immunity to         
P. falciparum malaria by using these epitopes as marker 
antigens, especially in younger age groups where low 
antibody responses and high parasite episodes could 
throw light in malaria prevention and control 
programme. Malaria epidemiology and transmission, in 
particular, is highly affected even by minor differences 
in environmental conditions. This type of study that 
take into account of microepidemiological approach 
and compares very close areas with slightly distinct 
characteristics are important to assess the patterns of 
establishment of malaria parasites in an area and 
response of human populations to them.  
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